|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/519 | |||
| A61K 31/4162 | |||
| A61P 11/00 |
| (11) | Number of the document | 3554506 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17879832.8 |
| Date of filing the European patent application | 2017-12-14 | |
| (97) | Date of publication of the European application | 2019-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/066317 |
| Date | 2017-12-14 |
| (87) | Number | WO 2018/112149 |
| Date | 2018-06-21 |
| (30) | Number | Date | Country code |
| 201662435253 P | 2016-12-16 | US |
| (72) |
STROHBACH, Joseph, Walter, US
LIMBURG, David, Christopher, US
MATHIAS, John, Paul, US
THORARENSEN, Atli, US
MOUSSEAU, James, John, US
DENNY, Rajiah, Aldrin, US
ZAPF, Christoph, Wolfgang, US
EFREMOV, Ivan, Viktorovich, US
|
| (73) |
Cystic Fibrosis Foundation,
4550 Montgomery Avenue, Suite 1100 N, Bethesda, MD 20814,
US
|
| (54) | BYCYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS |
| BYCYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS |